Cargando…

CD52 Is Elevated on B cells of SLE Patients and Regulates B Cell Function

Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by B cell dysregulation and breaks in tolerance that lead to the production of pathogenic autoantibodies. We performed single-cell RNA sequencing of B cells from healthy donors and individuals with SLE which revealed upregulat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bhamidipati, Kartik, Silberstein, John L., Chaichian, Yashaar, Baker, Matthew C., Lanz, Tobias V., Zia, Amin, Rasheed, Yusuf S., Cochran, Jennifer R., Robinson, William H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7917337/ https://www.ncbi.nlm.nih.gov/pubmed/33658999 http://dx.doi.org/10.3389/fimmu.2020.626820

Ejemplares similares

Mechanisms of B cell autoimmunity in SLE
por: Dörner, Thomas, et al.
Publicado: (2011)

BTLA Expression and Function Are Impaired on SLE B Cells
por: Wiedemann, Annika, et al.
Publicado: (2021)

B Cell Tolerance and Targeted Therapies in SLE
por: Parodis, Ioannis, et al.
Publicado: (2023)

Unraveling Race, Socioeconomic Factors, and Geographical Context in the Heterogeneity of Lupus Mortality in the United States
por: Falasinnu, Titilola, et al.
Publicado: (2019)

The Representation of Gender and Race/Ethnic Groups in Randomized Clinical Trials of Individuals with Systemic Lupus Erythematosus
por: Falasinnu, Titilola, et al.
Publicado: (2018)

B cells at the adaptive-innate immune system interface in SLE
por: Anolik, JH, et al.
Publicado: (2012)

B cell alterations during BAFF inhibition with belimumab in SLE
por: Ramsköld, Daniel, et al.
Publicado: (2018)

Epigenetic programming underpins B cell dysfunction in human SLE
por: Scharer, Christopher D., et al.
Publicado: (2019)

Regulation of B Cell Responses in SLE by Three Classes of Interferons
por: Domeier, Phillip P., et al.
Publicado: (2021)

The Other Function: Class II-Restricted Antigen Presentation by B Cells
por: Adler, Lital N., et al.
Publicado: (2017)

CD4(+) T-cell cooperation promoted pathogenic function of activated naïve B cells of patients with SLE
por: Wangriatisak, Kittikorn, et al.
Publicado: (2022)

miRNA-Mediated Control of B Cell Responses in Immunity and SLE
por: Schell, Stephanie L., et al.
Publicado: (2021)

Treatment of B cells malignancies with anti-CD19 CAR+, TCR-, CD52- allogeneic T cells
por: Mannioui, Cécile Schiffer, et al.
Publicado: (2013)

CD8+ T-Cells in Juvenile-Onset SLE: From Pathogenesis to Comorbidities
por: Ciurtin, Coziana, et al.
Publicado: (2022)

Profound inhibition of CD73-dependent formation of anti-inflammatory adenosine in B cells of SLE patients
por: Hesse, Julia, et al.
Publicado: (2021)

Efficacy and safety of atacicept for prevention of flares in patients with moderate-to-severe systemic lupus erythematosus (SLE): 52-week data (APRIL-SLE randomised trial)
por: Isenberg, David, et al.
Publicado: (2015)

Selective dysregulation of the FcγIIB receptor on memory B cells in SLE
por: Mackay, Meggan, et al.
Publicado: (2006)

IL-21 drives expansion and plasma cell differentiation of autoreactive CD11c(hi)T-bet(+) B cells in SLE
por: Wang, Shu, et al.
Publicado: (2018)

Complement Receptor Type 1 Suppresses Human B Cell Functions in SLE Patients
por: Kremlitzka, Mariann, et al.
Publicado: (2016)

Dysregulated CD38 Expression on Peripheral Blood Immune Cell Subsets in SLE
por: Burns, Marie, et al.
Publicado: (2021)

Tripartite Motif Containing 52 (TRIM52) Promotes Cell Proliferation in Hepatitis B Virus-Associated Hepatocellular Carcinoma
por: Zhang, Yi, et al.
Publicado: (2017)

B cell OX40L supports T follicular helper cell development and contributes to SLE pathogenesis
por: Cortini, Andrea, et al.
Publicado: (2017)

Efficient display of active lipase LipB52 with a Pichia pastoris cell surface display system and comparison with the LipB52 displayed on Saccharomyces cerevisiae cell surface
por: Jiang, Zhengbing, et al.
Publicado: (2008)

B-cell depletion in SLE: clinical and trial experience with rituximab and ocrelizumab and implications for study design
por: Reddy, Venkat, et al.
Publicado: (2013)

Age-Associated B Cells (ABCs) in the Prognosis, Diagnosis and Therapy of Systemic Lupus Erythematosus (SLE)
por: Sachinidis, Athanasios, et al.
Publicado: (2020)

Phenotypic Characterization of SLe(x)+ and CLA+ CD4+ T Cells
por: Kuri-Cervantes, Leticia, et al.
Publicado: (2020)

B cell-activating factor (BAFF) from dendritic cells, monocytes and neutrophils is required for B cell maturation and autoantibody production in SLE-like autoimmune disease
por: Giordano, Daniela, et al.
Publicado: (2023)

Characterization of RA33 (hnRNP-A2/B1)-autoreactive T cells in SLE-patients
por: Fritsch, R, et al.
Publicado: (2001)

Cytoplasmic FOXO1 identifies a novel disease-activity associated B cell phenotype in SLE
por: Hritzo Ahye, Molly K, et al.
Publicado: (2018)

Immune complex–driven neutrophil activation and BAFF release: a link to B cell responses in SLE
por: Wang, Ting, et al.
Publicado: (2022)

Anti-dsDNA B-Cell ELISpot as a Monitoring and Flare Prediction Tool in SLE Patients
por: Pérez-Isidro, Albert, et al.
Publicado: (2023)

Phase II, randomised, double-blind, multicentre study evaluating the safety and efficacy of filgotinib and lanraplenib in patients with lupus membranous nephropathy
por: Baker, Matthew, et al.
Publicado: (2020)

Identity of mysterious CD4(+)CD25(-)Foxp3(+ )cells in SLE
por: Horwitz, David A
Publicado: (2010)

Phenotypical changes and clinical significance of CD4(+)/CD8(+) T cells in SLE
por: Yuan, Shiwen, et al.
Publicado: (2022)

Takayasu's arteritis is associated with HLA-B*52, but not with HLA-B*51, in Turkey
por: Sahin, Ziver, et al.
Publicado: (2012)

The Problem of Pain in Rheumatology: Clinical Profiles Associated With Concomitant Diagnoses With Chronic Overlapping Pain Conditions
por: Falasinnu, Titilola, et al.
Publicado: (2022)

Contribution of abnormal BMI to adverse health-related quality of life outcomes after a 52-week therapy in patients with SLE
por: Borg, Alexander, et al.
Publicado: (2021)

YpeB dimerization may be required to stabilize SleB for effective germination of Bacillus anthracis spores
por: Sayer, Cameron V., et al.
Publicado: (2019)

Gender Differences of B Cell Signature in Healthy Subjects Underlie Disparities in Incidence and Course of SLE Related to Estrogen
por: Fan, Hongye, et al.
Publicado: (2014)

ATAC-seq on biobanked specimens defines a unique chromatin accessibility structure in naïve SLE B cells
por: Scharer, Christopher D., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_lnfmkb08d5qqdgdba08asadh0l